Prestige Consumer Healthcare Newsroom

Generational Group Announces Sale of Denmark Sausage Co. to Premium Brands

Seeking AlphaApr 25 16:13 ET

Is Prestige Consumer Healthcare Inc. (NYSE:PBH) Trading At A 43% Discount?

Simply Wall StApr 11 11:56 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

Prestige Consumer Healthcare IncApr 10 00:00 ET

Smile in Strides: Goody's Pain Relief Encourages Runners to Harness the Power of a Simple Smile to Reduce Pain and Boost Performance

PR NewswireApr 8 11:02 ET

Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stock

BenzingaMar 21 17:00 ET

Correction to Premium Brands Holdings Rating

Dow JonesMar 21 13:43 ET · Ratings

CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings.

BenzingaMar 21 12:51 ET · Ratings

Express News | CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings

BenzingaMar 21 12:51 ET

Express News | RBC Capital Maintains Sector Perform on Prestige Consumer, Raises Price Target to $97

BenzingaMar 21 12:35 ET

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Simply Wall StMar 21 10:50 ET

Earnings Scheduled For March 21, 2025

BenzingaMar 21 04:32 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Top Executive Sells Thousands of Prestige Consumer Healthcare Shares!

TipRanksMar 5 21:16 ET

William Blair Initiates Prestige Consumer Healthcare(PBH.US) With Buy Rating

Moomoo NewsMar 3 06:31 ET · Ratings

Prestige Consumer Healthcare: Undervalued Growth Potential With Strong Financial Performance and Shareholder Return Prospects

TipRanksMar 3 06:19 ET

Investing in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Would Have Delivered You a 116% Gain

Simply Wall StFeb 28 08:47 ET

Prestige Consumer Healthcare Insider Sold Shares Worth $959,271, According to a Recent SEC Filing

MT NewswiresFeb 13 16:23 ET

Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93

Moomoo NewsFeb 13 08:31 ET · Ratings